Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$147,354.00
Agreement Date:
Mar 1, 2017 - Feb 29, 2020
Description:
A randomized phase II trial of bortezomib-based therapy plus doxycycline vs. bortezomib-based chemotherapy plus standard supportive therapy in cardiac AL amyloidosis
Organization:
Canadian Institutes of Health Research
Location:
Edmonton, Alberta, CA T6G 2E1
Reference Number:
236-2016-2017-Q4-00337
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2016-17 to 2019-20)

Recipient's Legal Name:
Venner, Christopher P
Research Organization:
University of Alberta